![Outpatient Treatment of Recent-Onset Atrial Fibrillation with the “Pill -in-the-Pocket” Approach | NEJM Outpatient Treatment of Recent-Onset Atrial Fibrillation with the “Pill -in-the-Pocket” Approach | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.351.issue-23/nejmoa041233/production/images/img_medium/nejmoa041233_t1.jpeg)
Outpatient Treatment of Recent-Onset Atrial Fibrillation with the “Pill -in-the-Pocket” Approach | NEJM
Clinical effectiveness of a systematic ``pill-in-the-pocket'' approach for the management of paroxysmal atrial fibrillat
![Frontiers | “Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism Frontiers | “Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism](https://www.frontiersin.org/files/Articles/447223/fphys-10-00353-HTML/image_m/fphys-10-00353-g004.jpg)
Frontiers | “Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism
Clinical effectiveness of a systematic ``pill-in-the-pocket'' approach for the management of paroxysmal atrial fibrillat
![PDF) Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment PDF) Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment](https://i1.rgstatic.net/publication/42638878_Intravenous_administration_of_flecainide_or_propafenone_in_patients_with_recent-onset_atrial_fibrillation_does_not_predict_adverse_effects_during_'pill-in-the-pocket'_treatment/links/55b35c0d08aec0e5f431f508/largepreview.png)
PDF) Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment
![PDF] ATRIAL FIBRILLATION IN DAILY PRACTICE BENEFIT AND CONCERN ABOUT THE “ PILL-INTHE-POCKET | Semantic Scholar PDF] ATRIAL FIBRILLATION IN DAILY PRACTICE BENEFIT AND CONCERN ABOUT THE “ PILL-INTHE-POCKET | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ea3ec6985338e3899f6626979f6284fb1cb9bb25/1-Figure1-1.png)
PDF] ATRIAL FIBRILLATION IN DAILY PRACTICE BENEFIT AND CONCERN ABOUT THE “ PILL-INTHE-POCKET | Semantic Scholar
![Enlightened Medical Management of Atrial Fibrillation, Part II: The Pill In The Pocket Approach – The Skeptical Cardiologist Enlightened Medical Management of Atrial Fibrillation, Part II: The Pill In The Pocket Approach – The Skeptical Cardiologist](https://i0.wp.com/theskepticalcardiologist.com/wp-content/uploads/2019/07/pill-in-pocket-flecainide-2707148054-1568730542352.jpg?resize=609%2C463&ssl=1)
Enlightened Medical Management of Atrial Fibrillation, Part II: The Pill In The Pocket Approach – The Skeptical Cardiologist
![Management Strategies Marc D. Schrode, D.O., F.A.C.C.,F.A.C.O.I. Atrial Fibrillation. - ppt download Management Strategies Marc D. Schrode, D.O., F.A.C.C.,F.A.C.O.I. Atrial Fibrillation. - ppt download](https://images.slideplayer.com/12/3499110/slides/slide_28.jpg)
Management Strategies Marc D. Schrode, D.O., F.A.C.C.,F.A.C.O.I. Atrial Fibrillation. - ppt download
![Enlightened Medical Management of Atrial Fibrillation, Part II: The Pill In The Pocket Approach – The Skeptical Cardiologist Enlightened Medical Management of Atrial Fibrillation, Part II: The Pill In The Pocket Approach – The Skeptical Cardiologist](https://i0.wp.com/theskepticalcardiologist.com/wp-content/uploads/2019/07/Vancouver-PIP-sheet1.png?resize=526%2C778&ssl=1)
Enlightened Medical Management of Atrial Fibrillation, Part II: The Pill In The Pocket Approach – The Skeptical Cardiologist
![Antiarrhythmic Drugs for Atrial Fibrillation in the Outpatient Setting: Common Clinical Scenarios and Pearls for the Primary Care Clinician - ScienceDirect Antiarrhythmic Drugs for Atrial Fibrillation in the Outpatient Setting: Common Clinical Scenarios and Pearls for the Primary Care Clinician - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0025619621000471-gr4.jpg)
Antiarrhythmic Drugs for Atrial Fibrillation in the Outpatient Setting: Common Clinical Scenarios and Pearls for the Primary Care Clinician - ScienceDirect
![PDF] Outpatient treatment of recent-onset atrial fibrillation with the "pill -in-the-pocket" approach. | Semantic Scholar PDF] Outpatient treatment of recent-onset atrial fibrillation with the "pill -in-the-pocket" approach. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/880f23214bb4e5993c8e8ff5a4aaa1634a0be454/5-Table1-1.png)
PDF] Outpatient treatment of recent-onset atrial fibrillation with the "pill -in-the-pocket" approach. | Semantic Scholar
![2021 AF Symposium: New Technologies and Drugs―Flecainide Inhaler by InCarda - Atrial Fibrillation: Resources for PatientsAtrial Fibrillation: Resources for Patients 2021 AF Symposium: New Technologies and Drugs―Flecainide Inhaler by InCarda - Atrial Fibrillation: Resources for PatientsAtrial Fibrillation: Resources for Patients](https://i0.wp.com/a-fib.com/wp-content/uploads/2021/02/AF-Symposium-Block-2021-400-pix-sq-min.png?fit=400%2C400&ssl=1)
2021 AF Symposium: New Technologies and Drugs―Flecainide Inhaler by InCarda - Atrial Fibrillation: Resources for PatientsAtrial Fibrillation: Resources for Patients
![during ' pill-inthe-pocket ' treatment fibrillation does not predict adverse effects propafenone in patients with recent-onset atrial Intravenous administration of flecainide or | Semantic Scholar during ' pill-inthe-pocket ' treatment fibrillation does not predict adverse effects propafenone in patients with recent-onset atrial Intravenous administration of flecainide or | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/935ebb98a4648536410cdba751b0a37b34ba0c6c/4-Table1-1.png)